31 sources·Health

Anthem Blue Cross Blue Shield Reverses Anesthesia Policy Amid Outrage Following CEO Shooting

Anthem Blue Cross Blue Shield halts controversial anesthesia reimbursement policy after backlash linked to public outrage over UnitedHealthcare CEO's assassination.

19%

48%

32%

The distribution of story sources: left-leaning (blue), center (light gray), and right-leaning (red).

Mostly Reliable

The underlying sources are generally reliable but sometimes include opinion, propaganda, or minor inaccuracies.

Balanced

The underlying sources are either a balanced mix of left and right or primarily centrist.

No highlights available for this story.

Updated: Dec 6th, 2024, 2:28 PM ET

Summary

A summary of the key points of this story verified across multiple sources.

Anthem Blue Cross Blue Shield has decided not to move forward with a controversial policy to cap anesthesia reimbursements based on surgical durations, a reversal following public uproar after the assassination of UnitedHealthcare CEO Brian Thompson. The insurer faced significant pushback, particularly from the American Society of Anesthesiologists, and accusations of inadequate patient care. In response to the backlash and political intervention from New York and Connecticut officials, Anthem clarified their commitment to covering medically necessary anesthesia services.

Perspectives

Compare opinions on this story from liberal (Left), conservative (Right) or center-leaning news organizations.

No center-leaning sources available for this story.

History

A summary of how this story has evolved over the last 24 hours.